Characteristics and treatment patterns among US patients with hairy cell leukemia: a retrospective claims analysis.

about

Hairy cell leukemia 2018: Update on diagnosis, risk-stratification, and treatment.Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia

P2860

Q47170848-268A6D65-F67B-4293-AAF7-A4A37C04DE4E Q56355787-49FA6FB3-EBF2-4196-A6C5-1651BB29C265

P2860

Characteristics and treatment patterns among US patients with hairy cell leukemia: a retrospective claims analysis.

Item

http://www.wikidata.org/entity/Q53304785

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Characteristics and treatment ...... retrospective claims analysis.

@en

Characteristics and treatment ...... retrospective claims analysis.

@nl

type

Item

label

Characteristics and treatment ...... retrospective claims analysis.

@en

Characteristics and treatment ...... retrospective claims analysis.

@nl

prefLabel

Characteristics and treatment ...... retrospective claims analysis.

@en

Characteristics and treatment ...... retrospective claims analysis.

@nl

P1476

Characteristics and treatment ...... retrospective claims analysis.

@en

P2093

Andrew Gaughan

http://www.w3.org/2001/XMLSchema#string

Guozhi Gao

http://www.w3.org/2001/XMLSchema#string

Kevin B Knopf

http://www.w3.org/2001/XMLSchema#string

Mark C Lanasa

http://www.w3.org/2001/XMLSchema#string

Mitch DeKoven

http://www.w3.org/2001/XMLSchema#string

Sudeep Karve

http://www.w3.org/2001/XMLSchema#string

Victoria Divino

http://www.w3.org/2001/XMLSchema#string

P2860

Hairy cell leukemia: Update on molecular profiling and therapeutic advances

How I treat hairy cell leukemia.

Autoimmune conditions and hairy cell leukemia: an exploratory case-control study.

Systemic Therapy for Metastatic Colorectal Cancer: Patterns of Chemotherapy and Biologic Therapy Use in US Medical Oncology Practice.

Update on the biology and treatment options for hairy cell leukemia.

Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis.

My treatment approach to hairy cell leukemia.

Hairy cell leukemia: short review, today's recommendations and outlook.

Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia.

Long-term results for pentostatin and cladribine treatment of hairy cell leukemia.

P304

497-508

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/CER-2017-0014

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28485619

http://www.w3.org/2001/XMLSchema#string

Characteristics and treatment patterns among US patients with hairy cell leukemia: a retrospective claims analysis.

about

P2860

P2860

Characteristics and treatment patterns among US patients with hairy cell leukemia: a retrospective claims analysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698